blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3860623

EP3860623 - METHODS OF TREATING BASAL CELL CARCINOMA AND GLIOBLASTOMA [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  10.03.2023
Database last updated on 16.11.2024
FormerRequest for examination was made
Status updated on  09.07.2021
FormerThe international publication has been made
Status updated on  18.04.2020
Most recent event   Tooltip30.10.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Buck, Carol J.
30 Brooks Bend
Princeton, NJ 08540 / US
[2021/32]
Inventor(s)01 / see applicant
...
 [2021/32]
Representative(s)FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39 / IE
[N/P]
Former [2021/32]FRKelly
27 Clyde Road
Dublin D04 F838 / IE
Application number, filing date19871069.107.10.2019
[2021/32]
WO2019US54994
Priority number, dateUS20181615555809.10.2018         Original published format: US201816155558
US20191639305324.04.2019         Original published format: US201916393053
[2021/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020076695
Date:16.04.2020
Language:EN
[2020/16]
Type: A1 Application with search report 
No.:EP3860623
Date:11.08.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 16.04.2020 takes the place of the publication of the European patent application.
[2021/32]
Search report(s)International search report - published on:US16.04.2020
(Supplementary) European search report - dispatched on:EP13.06.2022
ClassificationIPC:A61K35/04, A61K31/015, A61K31/403, A61K31/343, A61K31/47, A61P35/00, A61K9/00, A61K47/10, A61K47/12, A61K47/36, A61K47/44
[2022/28]
CPC:
A61P35/00 (EP,US); A61K35/04 (EP,US); A61K31/015 (EP);
A61K31/403 (EP); A61K31/47 (EP); A61K31/4745 (EP);
A61K31/513 (EP); A61K36/87 (EP,US); A61K45/06 (EP,US);
A61K47/10 (EP); A61K47/12 (EP); A61K47/36 (EP);
A61K47/44 (EP,US); A61K9/0019 (EP,US); A61K9/007 (US) (-)
C-Set:
A61K31/4745, A61K2300/00 (EP);
A61K31/513, A61K2300/00 (EP);
A61K35/04, A61K2300/00 (EP);
A61K36/87, A61K2300/00 (EP)
Former IPC [2021/32]A61K35/04, A61K35/00, A61K31/05, A61K31/403, A61K31/343, A61K31/47
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/32]
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON BASALZELLKARZINOM UND GLIOBLASTOM[2021/32]
English:METHODS OF TREATING BASAL CELL CARCINOMA AND GLIOBLASTOMA[2021/32]
French:MÉTHODES DE TRAITEMENT DU CARCINOME BASOCELLULAIRE ET DU GLIOBLASTOME[2021/32]
Entry into regional phase04.05.2021National basic fee paid 
04.05.2021Search fee paid 
04.05.2021Designation fee(s) paid 
04.05.2021Examination fee paid 
Examination procedure04.05.2021Examination requested  [2021/32]
28.10.2022Amendment by applicant (claims and/or description)
09.03.2023Despatch of a communication from the examining division (Time limit: M04)
06.06.2023Reply to a communication from the examining division
Divisional application(s)EP23188188.9  / EP4241788
Fees paidRenewal fee
04.05.2021Renewal fee patent year 03
08.08.2022Renewal fee patent year 04
19.09.2023Renewal fee patent year 05
30.10.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XD]US6337337  (BUCK CAROL J [US]) [XD] 12 * claims 1-12 * * columns 7-8; example 9 *;
 [A]  - CHRISTENSEN E ET AL, "High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study", BRITISH JOURNAL OF DERMATOLOGY, JOHN WILEY, HOBOKEN, USA, (20120525), vol. 166, no. 6, doi:10.1111/J.1365-2133.2012.10878.X, ISSN 0007-0963, pages 1342 - 1348, XP071053329 [A] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1111/j.1365-2133.2012.10878.x
 [A]  - PAOLILLO MAYRA ET AL, "Glioblastoma under Siege: An Overview of Current Therapeutic Strategies", BRAIN SCIENCES, (20180116), vol. 8, no. 1, doi:10.3390/brainsci8010015, pages 1 - 13, XP055926645 [A] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.3390/brainsci8010015
International search[A]US3987202  (OKUN MILTON R) [A] 1-20* , entire document. *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.